PROCESSING FACTORS AFFECTING PARTICLE-SIZE AND IN-VITRO DRUG-RELEASE OF SUSTAINED-RELEASE IBUPROFEN MICROSPHERES

被引:10
作者
ALKASSAS, RS [1 ]
GILLIGAN, CA [1 ]
PO, ALW [1 ]
机构
[1] QUEENS UNIV BELFAST,CTR MED BIOL,DEPT PEDIAT,97 LISBURN RD,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND
关键词
SUSTAINED RELEASE; MICROSPHERE; MATRIX; IBUPROFEN;
D O I
10.1016/0378-5173(93)90009-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ibuprofen microspheres were prepared using an aqueous dispersion method. The method was adapted so that two processing factors, cooling time and stirring rate, could be altered. The subsequent effects of altering these parameters on the characterisation of the microspheres and the drug release kinetics were investigated. Particle size analysis showed that both stirring rate and cooling time significantly affected the mean particle size although the effects were independent of each other. In vitro release data were fitted to several models, the Higuchi square root of time model (with appropriate limits) giving the best fit for the release data. Increasing the cooling time or decreasing the stirring rate decreased the release of drug from the system. By using this method of manufacture, which allows alteration of processing parameters, it would be relatively straightforward to produce microspheres with tailored in vitro release characteristics.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 14 条
[1]   SOME BIOLOGICAL PROPERTIES OF 2-(4-ISOBUTYLPHENYL)-PROPIONIC ACID [J].
ADAMS, SS ;
CLIFFE, EE ;
LESSEL, B ;
NICHOLSON, JS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (12) :1686-+
[2]  
ADAMS SS, 1969, ARCH INT PHARMACOD T, V178, P115
[3]   5-FLUOROURACIL - CARNAUBA WAX MICROSPHERES FOR CHEMOEMBOLIZATION - AN INVITRO EVALUATION [J].
BENITA, S ;
ZOUAI, O ;
BENOIT, JP .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (09) :847-851
[4]  
BISWANATH S, 1990, DRUG DEV IND PHARM, V16, P1153
[5]   SPHERICAL AGGLOMERATES OF WATER-INSOLUBLE DRUGS [J].
BODMEIER, R ;
PAERATAKUL, O .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (11) :964-967
[6]  
DAS SK, 1988, DRUG DEV IND PHARM, V14, P1605
[7]   A METHOD OF PREPARING GELATIN MICROCAPSULES [J].
DHUPAR, KC .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (06) :1023-1030
[8]   SOME WAX FORMULATIONS OF SULFAETHYLTHIADIAZOLE PRODUCED BY AQUEOUS DISPERSION FOR PROLONGED-RELEASE MEDICATION [J].
DRAPER, EB ;
BECKER, CH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (04) :376-&
[9]   GLC DETERMINATION OF IBUPROFEN [(+/-)-2-(P-ISOBUTYLPHENYL)PROPIONIC ACID] IN PLASMA [J].
KAISER, DG ;
VANGIESSEN, GJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (02) :219-221
[10]   PREPARATION OF CONTROLLED-RELEASE MICROSPHERES OF IBUPROFEN WITH ACRYLIC POLYMERS BY A NOVEL QUASI-EMULSION SOLVENT DIFFUSION METHOD [J].
KAWASHIMA, Y ;
NIWA, T ;
HANDA, T ;
TAKEUCHI, H ;
IWAMOTO, T ;
ITOH, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (01) :68-72